Hepatitis E Virus: Comprehensive Virological Insights, Diagnostic Strategies, and Laboratory Management for Clinical and Research Specialists
Abstract
Background: Hepatitis E virus (HEV) is a major global cause of acute viral hepatitis, with significant morbidity and mortality in high-risk populations. It is a non-enveloped, single-stranded RNA virus transmitted primarily via the fecal-oral route, though zoonotic transmission is increasingly recognized.
Aim: This review provides a comprehensive update on HEV for clinical and research specialists, covering its virology, diagnostic strategies, and laboratory management to improve detection and patient care.
Methods: The synthesis is based on a detailed analysis of HEV's virological characteristics, including its genotypes and their distinct epidemiological patterns. Diagnostic approaches are evaluated, comparing serological assays (anti-HEV IgM/IgG) and molecular methods (PCR for HEV RNA) for acute and chronic infection.
Results: HEV genotypes 1 and 2 cause waterborne outbreaks in developing regions, while genotypes 3 and 4 are zoonotic and responsible for sporadic cases in developed countries. Infection is often self-limiting but can lead to fulminant hepatitis in pregnant women and chronic infection in immunocompromised individuals. Diagnosis relies on a combination of serology and PCR, with the latter being essential for confirming chronic infection in immunosuppressed patients where antibody responses may be blunted.
Conclusion: HEV is a complex pathogen with a variable clinical presentation. Accurate diagnosis requires an understanding of its virology and the strategic use of laboratory tests. Enhanced surveillance, targeted testing in high-risk groups, and a multidisciplinary approach are crucial for effective management and prevention.
Full text article
References
Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, Poleschuk VF. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23-31.
Kane MA, Bradley DW, Shrestha SM, Maynard JE, Cook EH, Mishra RP, Joshi DD. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets. JAMA. 1984 Dec 14;252(22):3140-5.
Yamashita T, Mori Y, Miyazaki N, Cheng RH, Yoshimura M, Unno H, Shima R, Moriishi K, Tsukihara T, Li TC, Takeda N, Miyamura T, Matsuura Y. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A. 2009 Aug 04;106(31):12986-91.
Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med. 1980 Jun;68(6):818-24.
Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med. 2012 Sep 27;367(13):1237-44.
Arankalle VA, Chadha MS, Mehendale SM, Banerjee K. Outbreak of enterically transmitted non-A, non-B hepatitis among schoolchildren. Lancet. 1988 Nov 19;2(8621):1199-200.
Tsega E, Krawczynski K, Hansson BG, Nordenfelt E, Negusse Y, Alemu W, Bahru Y. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol. 1991 Aug;34(4):232-6.
Velázquez O, Stetler HC, Avila C, Ornelas G, Alvarez C, Hadler SC, Bradley DW, Sepúlveda J. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987. JAMA. 1990 Jun 27;263(24):3281-5.
Emerson SU, Purcell RH. Running like water--the omnipresence of hepatitis E. N Engl J Med. 2004 Dec 02;351(23):2367-8.
Centers for Disease Control and Prevention (CDC). Hepatitis E among U.S. travelers, 1989-1992. MMWR Morb Mortal Wkly Rep. 1993 Jan 15;42(1):1-4.
De Cock KM, Bradley DW, Sandford NL, Govindarajan S, Maynard JE, Redeker AG. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med. 1987 Feb;106(2):227-30.
Fortier D, Treadwell TL, Koff RS. Enterically transmitted non-A, non-B hepatitis: importation from Mexico to Massachusetts. N Engl J Med. 1989 May 11;320(19):1281-2.
Ditah I, Ditah F, Devaki P, Ditah C, Kamath PS, Charlton M. Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology. 2014 Sep;60(3):815-22.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018 Jun;68(6):1256-1271.
Letafati A, Taghiabadi Z, Roushanzamir M, Memarpour B, Seyedi S, Farahani AV, Norouzi M, Karamian S, Zebardast A, Mehrabinia M, Ardekani OS, Fallah T, Khazry F, Daneshvar SF, Norouzi M. From discovery to treatment: tracing the path of hepatitis E virus. Virol J. 2024 Aug 23;21(1):194.
Wasuwanich P, Wen TS, Egerman RS, Karnsakul W. Epidemiology and Outcomes of Hepatitis E Virus-Associated Hospitalisations in the United States With a Focus on Pregnancy: A Nationwide Population Study, 1998-2020. J Viral Hepat. 2024 Nov;31(11):710-719.
Teo CG. Fatal outbreaks of jaundice in pregnancy and the epidemic history of hepatitis E. Epidemiol Infect. 2012 May;140(5):767-87.
Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008 Nov;8(11):698-709.
Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, Das BC. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol. 2008 Oct;103(10):2495-501.
Willauer AN, Sherman KE. Hepatitis E virus: has anything changed? Curr Opin Gastroenterol. 2023 May 01;39(3):169-174.
Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003 Aug 02;362(9381):371-3.
Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004 Jul;19(7):778-84.
Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet. 1995 Apr 22;345(8956):1025-6.
Rivero-Juarez A, Frias M, Rodriguez-Cano D, Cuenca-López F, Rivero A. Isolation of Hepatitis E Virus From Breast Milk During Acute Infection. Clin Infect Dis. 2016 Jun 01;62(11):1464
Kapur N, Thakral D, Durgapal H, Panda SK. Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis. J Viral Hepat. 2012 Jun;19(6):436-48.
Krawczynski K, Meng XJ, Rybczynska J. Pathogenetic elements of hepatitis E and animal models of HEV infection. Virus Res. 2011 Oct;161(1):78-83.
Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet. 2012 Jun 30;379(9835):2477-2488.
Lenggenhager D, Pawel S, Honcharova-Biletska H, Evert K, Wenzel JJ, Montani M, Furrer E, Fraga M, Moradpour D, Sempoux C, Weber A. The histologic presentation of hepatitis E reflects patients' immune status and pre-existing liver condition. Mod Pathol. 2021 Jan;34(1):233-248.
Woolson KL, Forbes A, Vine L, Beynon L, McElhinney L, Panayi V, Hunter JG, Madden RG, Glasgow T, Kotecha A, Dalton HC, Mihailescu L, Warshow U, Hussaini HS, Palmer J, Mclean BN, Haywood B, Bendall RP, Dalton HR. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther. 2014 Dec;40(11-12):1282-91.
Halac U, Béland K, Lapierre P, Patey N, Ward P, Brassard J, Houde A, Alvarez F. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr. 2012 May;160(5):871-4.e1.
Centers for Disease Control (CDC). Enterically transmitted non-A, non-B hepatitis--East Africa. MMWR Morb Mortal Wkly Rep. 1987 May 01;36(16):241-4.
Geurtsvankessel CH, Islam Z, Mohammad QD, Jacobs BC, Endtz HP, Osterhaus AD. Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis. 2013 Nov;57(9):1369-70.
Takahashi M, Kusakai S, Mizuo H, Suzuki K, Fujimura K, Masuko K, Sugai Y, Aikawa T, Nishizawa T, Okamoto H. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005 Jan;43(1):49-56.
Baylis SA, Hanschmann KM, Blümel J, Nübling CM., HEV Collaborative Study Group. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol. 2011 Apr;49(4):1234-9.
Khudyakov Y, Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res. 2011 Oct;161(1):84-92.
Khuroo MS, Khuroo MS. Hepatitis E: an emerging global disease - from discovery towards control and cure. J Viral Hepat. 2016 Feb;23(2):68-79.
Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011 May;140(5):1481-9.
Shalimar, Acharya SK. Hepatitis e and acute liver failure in pregnancy. J Clin Exp Hepatol. 2013 Sep;3(3):213-24.
Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, Dalton HR. Hepatitis E virus and neurologic disorders. Emerg Infect Dis. 2011 Feb;17(2):173-9.
Gupta T, Dhiman S, Sharma A. Menace of hepatitis E in pregnancy: unleashing the threat of fulminant liver failure. BMJ Case Rep. 2024 Mar 22;17(3)
Zicker M, Pinho JRR, Welter EAR, Guardia BD, da Silva PGTM, da Silveira LB, Camargo LFA. The Risk of Reinfection or Primary Hepatitis E Virus Infection at a Liver Transplant Center in Brazil: An Observational Cohort Study. Viruses. 2024 Feb 16;16(2)
Alexandrova R, Tsachev I, Kirov P, Abudalleh A, Hristov H, Zhivkova T, Dyakova L, Baymakova M. Hepatitis E Virus (HEV) Infection Among Immunocompromised Individuals: A Brief Narrative Review. Infect Drug Resist. 2024;17:1021-1040.
Hepatitis E vaccine: WHO position paper, May 2015. Wkly Epidemiol Rec. 2015 May 01;90(18):185-200.
Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ, Ai X, Hu YM, Tang Q, Yao X, Yan Q, Xian YL, Wu T, Li YM, Miao J, Ng MH, Shih JW, Xia NS. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010 Sep 11;376(9744):895-902.
Tsarev SA, Tsareva TS, Emerson SU, Govindarajan S, Shapiro M, Gerin JL, Purcell RH. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10198-202.
Authors
Copyright (c) 2025 Neamat Bakr Ali Tukruna, Hind Saad Mohammed Alabdulsalam, Rashad Mohammad Hayan, Ateyah Laheg Nami Alhadri, Fatimah Sared Alsaiari, Ahmed Abdu Ahmed Zalah, Saleh Ahmad S Alebaidi, Mohammad Zaher Alblowi, Mahhani Hamad Jafar, Hadeel Hassan Almadkhly, Walaa Abdulwahed, Salihah Ahmed Allaghabi, Ahmed Moner Alqerafi, Majdi Raji Naffa Alharbi, Roaa Ahmed Dweiri
This work is licensed under a Creative Commons Attribution 4.0 International License.